5-Fluorouracil sensitivity and dihydropyrimidine dehydrogenase activity in advanced gastric cancer

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2457-2462

  Inada, Takao ^a   Ogata, Yoshiro ^a   Kubota, Tetsuro ^b   Tomikawa, Moriaki ^a   Yamamoto, Seichiro ^a   Andoh, Jiro ^a   Ozawa, Iwao ^a   Hishinuma, Shoichi ^a   Shimizu, Hideaki ^a   Kotake, Kenjiro ^a  

^a TOCHIGI CANCER CENTER   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Chemosensitivity; Dihydropyrimidine dehydrogenase; Gastric cancer

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL;

ADVANCED CANCER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; STOMACH CANCER;

ANTIMETABOLITES, ANTINEOPLASTIC; DIHYDROURACIL DEHYDROGENASE (NADP); FLUOROURACIL; HUMANS; OXIDOREDUCTASES; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 0033862922     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Moertel CG: Chemotherapy for colorectal cancer. N Engl J Med 330: 1136-1143, 1994.
2. Spears CP, Shahinian AH, Moran RG, Heidelberger C and Corbett TH: In vivo kinetics of thymidylate synthetase inhibition in 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Caner Res 42: 450-456, 1982.
3. Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV and Leichman L: Thymidylate synthetase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 55: 1407-1412, 1995.
4. Matsuoka H, Ueno H, Sugimachi K, and Akiyoshi T: Preliminary evidence that incorporation of 5-fluorouracil into RNA correlates with antitumor response. Cancer Invest 10: 265-269, 1992.
5. Peters GJ, van der Wilt CL, Smid K, Meijer S and Pinedo HM: Thymidylate synthetase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. J Clin Oncol 12: 2035-2042, 1994.
6. Johnston PG, Lenz H-J, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV and Leichman L: Thymidylate synthetase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 55: 1407-1412, 1995.
7. Leichman CG, Lenz H-J, Leichman L, Danenberg K, Baranda J, Groshen S, Boswell W, Metzger R, Tan M and Danenberg PV: Quantitation of intratumoral thymidylate synthetase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 15: 3223-3229, 1997.
8. Peters GJ, Laurensse E, Leyva A, Lankelma J and Pinedo HM: Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5′ deoxy-5-fluorouridine in relation to drug-metabolizing enzymes. Cancer Res 46: 20-28, 1986.
9. Aschele C, Sobrero A, Faderan MA and Bertino JR: Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. Cancer Res 52: 1855-1864, 1992.
10. Naguib FNM, El Kouni AM and Cha S: Enzyme of uracil catabolism in normal and neoplastic human tissues. Cancer Res 45: 5405-5412, 1985.
11. Etienne MC, Cheradame S, Fishel JL, Formento P, Dassonville O, Renee N, Schneider M, Thyss A, Dermard F and Milano G: Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. J Clin Oncol 13: 1663-1670, 1995.
12. BeckA, Etienne MC, Cheradame S-, Fischel JL, Formento P, Renee N and Milano G: A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumor sensitivity to fluorouracil Eur J Cancer 30A: 1517-1522, 1994.
13. Jiang W, Lu Z, He Y and Diasio RB: Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy. Clin Cancer Res 3: 395-399, 1997.
14. McLeod HL, Sludden J, Murray GI, Keenan RA, Davidsen AI, Park K, Koruth M and Classidy J: Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Br J Cancer 77: 461-465, 1988.
15. Macdonald JS and Gohmann JJ: Chemotherapy of advanced gastric cancer: present status, future aspects. Semin Oncol 15(Supple 4): 42-49, 1988.
16. Hafstrom L, Rudenstam C-M, Domellof L and the Swedish Gastro-Intestinal Tumour Adjuvant Therapy Group: A randomized trial of oral 5-fluorouracil versus placebo as adjuvant therapy in colorectal cancer Dukes' B and C: results after 5 years observation time. Br J Surg 72: 138-141, 1985.
17. Kubota T, Sasano N, Abe O, Nakao I, Kawamura E, Saito T, Endo M, Kimura K, Demura H, Sasano H, Nagura H, Ogawa N, Hoffman RM and the Chemosensitivity Study Group for the Histoculture Drug-Response Assay: Potential of the histoculture drug-response assay to contribute to cancer patient survival. Clin Cancer Res 1: 1537-1543, 1995.